Back
Also listed as
SMDPY
OTC
Day Range
$13.36
$14.29
52-Week Range
$4.00
$19.20
Volume
801
50D / 200D Avg
$14.11
/
$11.50
Prev Close
$13.73
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (625 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 0.2 | 14.0 |
| P/B | 0.0 | 2.4 |
| ROE % | 14.5 | 11.4 |
| Net Margin % | 5.9 | 10.1 |
| Rev Growth 5Y % | -6.2 | 7.0 |
| D/E | 1.8 | 0.5 |
Key Takeaways
Revenue declined -6.23% annually over 5 years
ROE of 14.52% — decent returns on equity
Generating 3.47B in free cash flow
P/E of 0.22 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 33.02%
Capital efficient — spends only 3.27% of revenue on capex
Growth
Revenue Growth (5Y)
-6.23%
Revenue (1Y)26.79%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
14.52%
ROIC2.36%
Net Margin5.93%
Op. Margin3.74%
Safety
Debt / Equity
1.80
Current Ratio1.05
Interest Coverage1.11
Valuation
P/E Ratio
0.22
P/B Ratio0.03
EV/EBITDA19.27
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 26.79% | Revenue Growth (3Y) | -15.27% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -6.23% | Earnings Growth (5Y) | -19.48% |
| Profitability | |||
| Revenue (TTM) | 398.83B | Net Income (TTM) | 23.63B |
| ROE | 14.52% | ROA | 3.18% |
| Gross Margin | 61.53% | Operating Margin | 3.74% |
| Net Margin | 5.93% | Free Cash Flow (TTM) | 3.47B |
| ROIC | 2.36% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.80 | Current Ratio | 1.05 |
| Interest Coverage | 1.11 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 0.22 | P/B Ratio | 0.03 |
| P/S Ratio | 0.01 | PEG Ratio | -0.11 |
| EV/EBITDA | 19.27 | Dividend Yield | 0.00% |
| Market Cap | 5.31B | Enterprise Value | 287.61B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 398.83B | 314.56B | 555.54B | 560.04B | 515.95B |
| Net Income | 23.63B | -314.97B | -74.51B | 56.41B | 56.22B |
| EPS (Diluted) | 59.49 | -792.79 | -187.55 | 141.99 | 141.50 |
| Gross Profit | 245.40B | 187.98B | 376.63B | 402.91B | 378.18B |
| Operating Income | 14.93B | -354.86B | -76.98B | 60.23B | 71.22B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 742.60B | 907.51B | 1.13T | 1.31T | 1.31T |
| Total Liabilities | 573.13B | 751.37B | 727.96B | 634.44B | 659.95B |
| Shareholders' Equity | 169.48B | 156.06B | 406.75B | 607.89B | 580.57B |
| Total Debt | 305.42B | 427.86B | 334.72B | 269.05B | 273.82B |
| Cash & Equivalents | 23.12B | 29.05B | 143.48B | 202.98B | 193.70B |
| Current Assets | 253.17B | 269.57B | 381.86B | 499.52B | 459.80B |
| Current Liabilities | 240.60B | 515.47B | 372.69B | 278.37B | 278.15B |